Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders (Q38820487)

6 September 2017

Ketamine's dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders (English)

1 reference

6 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Andrew Gray

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Paul Glue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sarah Harland

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Shona Neehoff

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Bridie Anderson-Fahey

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Martin Le Nedelec

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Neil McNaughton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

English

0 references

publication date

1 April 2017

1 reference

Journal of Psychopharmacology

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1302-1305

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

Glutamate dysregulation and glutamatergic therapeutics for PTSD: Evidence from human studies

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Dose- and exposure-response to ketamine in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

The assessment of anxiety states by rating

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Placebo-controlled pilot trial testing dose titration and intravenous, intramuscular and subcutaneous routes for ketamine in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Brief standard self-rating for phobic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Investigating distinct and common abnormalities of resting-state functional connectivity in depression, anxiety, and their comorbid states

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Regional brain volume in depression and anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881117705089

21 January 2018

Identifiers

DOI

10.1177/0269881117705089

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28441895%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference